Stockscreener 앱 받기
19.07
2.05%
-0.40
시장 영업 전:
19.14
0.07
+0.37%
전일 마감가:
$19.47
열려 있는:
$19.62
하루 거래량:
686.54K
Relative Volume:
1.01
시가총액:
$1.39B
수익:
$188.48M
순이익/손실:
$-143.14M
주가수익비율:
-9.5829
EPS:
-1.99
순현금흐름:
$-158.83M
1주 성능:
-9.83%
1개월 성능:
-8.45%
6개월 성능:
-14.87%
1년 성능:
-32.85%
1일 변동 폭
$18.62
$19.76
1주일 범위
$18.20
$20.87
52주 변동 폭
$16.67
$33.63
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
SDGR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
19.07 | 1.39B | 188.48M | -143.14M | -158.83M | -1.99 |
|
VEEV
Veeva Systems Inc
|
210.86 | 34.23B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
70.19 | 12.13B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
50.77 | 9.48B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
103.61 | 8.98B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 6.43B | 906.14M | -52.62M | 89.62M | -0.3621 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
Goldman Sachs maintains Schrodinger stock at Neutral By Investing.com - Investing.com Canada
Goldman Sachs maintains Schrodinger stock at Neutral - Investing.com India
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
(SDGR) Technical Pivots with Risk Controls - Stock Traders Daily
Top 5 AI & Digital Biotech Companies (January 2025) - Securities.io
Schrödinger (NASDAQ:SDGR) Shares Up 3.4%What's Next? - MarketBeat
Schrödinger (NASDAQ:SDGR) Shares Down 6.7%Time to Sell? - MarketBeat
Barclays PLC Increases Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Jane Street Group LLC Has $1.80 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
State Street Corp Has $39.99 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)December 17, 2024 - BioSpace
Schrödinger Awards Inducement RSU Grants to New Employees Under 2021 Equity Plan - StockTitan
Schrödinger, Inc. (NASDAQ:SDGR) Receives $32.90 Consensus PT from Brokerages - MarketBeat
(SDGR) Investment Analysis and Advice - Stock Traders Daily
Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence - GlobeNewswire Inc.
How To Trade (SDGR) - Stock Traders Daily
Schrodinger Inc (SDGR) Trading Down 4.58% on Dec 5 - GuruFocus.com
Parkman Healthcare Partners LLC Trims Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Material Informatics Market Top Companies Study -Citrine - openPR
Rubric Capital Management LP Has $68.37 Million Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Stock Position Increased by Algert Global LLC - MarketBeat
Schrodinger Inc (SDGR) Stock Price Down 3.17% on Nov 26 - GuruFocus.com
Massachusetts Financial Services Co. MA Purchases 717,059 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates - MSN
Detailed Analysis of Molecular Modeling for Drug Development - openPR
Quest Partners LLC Purchases 39,218 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Schrödinger: Positive Signs Despite The Share Price Decline (SDGR) - Seeking Alpha
Gates Foundation awards second predictive toxicology grant - Philanthropy News Digest
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference - Business Wire
Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion - MSN
Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement - Genetic Engineering & Biotechnology News
SDGRSchrodinger, Inc. Latest Stock News & Market Updates - StockTitan
Schrödinger, Inc. Receives an Additional $9.5 Million from the Bill & Melinda Gates Foundation - Marketscreener.com
Biosimulation Market Dynamics and Future Opportunities | 2024 - openPR
Schrödinger Awards RSU Grants to New Employees Under Inducement Plan - StockTitan
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - BioSpace
Schrödinger Secures $9.5M Gates Foundation Grant to Expand Drug Discovery Platform - StockTitan
Sumitomo Mitsui Trust Group Inc. Increases Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for Schrödinger - MarketBeat
(SDGR) Technical Data - Stock Traders Daily
Schrodinger Inc (SDGR) Quarterly 10-Q Report - Quartz
Schrodinger (SDGR): Stock Experiences 5% Decline Amid Market Flu - GuruFocus.com
Pier 88 Investment Partners LLC Buys 35,120 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Midtown-based drug company inks $150M deal with Novartis - Crain's New York Business
Rubric Capital Management LP Increases Stake in Schrodinger Inc - GuruFocus.com
Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024 - Marketscreener.com
Schrodinger shares target increased, outperform rating on Novartis deal - Investing.com
Flare and Schrödinger join multibillion-dollar collaborations - BioWorld Online
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
15.30%
0.61%
자본화:
|
볼륨(24시간):